Remarkably, recent studies showed that SMURF2 could be phosphorylated by AKT [34] and ERK5 [35], two pro-tumorigenic serine/threonine kinases which expression and/or activities are upregulated in many cancers. The gene discussed is SMURF2; the disease is cancer.